PT Diagnos Laboratorium Utama Tbk
IDX:DGNS.JK
230 (IDR) • At close October 30, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PT Diagnos Laboratorium Utama Tbk |
Symbool | DGNS.JK |
Munteenheid | IDR |
Prijs | 246 |
Beurswaarde | 307,500,000,000 |
Dividendpercentage | 0% |
52-weken bereik | 188 - 436 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Engineer Mesha Rizal Sini |
Website | https://diagnos.co.id |
An error occurred while fetching data.
Over PT Diagnos Laboratorium Utama Tbk
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (IDR)
Cijfers zijn in miljoenen (IDR)